BioUtah News
-
Michele Baptista Joins CenExel Industry powerhouse brings expertise in early phase clinical trial services to CenExel site network
Salt Lake City, Utah — CenExel announces the addition of Michele Baptista as the new Senior Director of Business Development. In this new…
-
Biomerics Announces Merger with Precision Concepts Medical
Biomerics (“Biomerics” or the “Company”), the leading vertically integrated contract manufacturer for the interventional medical device market, announced…
-
Sera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield and Appointment of Board Member Zhenya Lindgardt as Interim CEO
SALT LAKE CITY, May 15, 2023 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on…
-
Recursion Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer
SALT LAKE CITY, May 16, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company…
-
Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development
SALT LAKE CITY and BOCA RATON, Fla. – May 15, 2023 – Nusano, Inc., a company reshaping the…
-
EY Announces Marcus Gerhardt and Florian Solzbacher of Blackrock Neurotech as Entrepreneur Of The Year® 2023 Mountain West Award Finalists
SALT LAKE CITY, May 8, 2023 – Ernst & Young LLP (EY US) today announced that Marcus Gerhardt,…
-
NUSANO ANNOUNCES IN-HOUSE STABLE ISOTOPE PROGRAM LED BY RENOWNED PHYSICIST SARKO CHEREKDJIAN
VALENCIA, Calif. and WEST VALLEY CITY, Utah – May 11, 2023 – Nusano, Inc., a company reshaping the…
-
Foldax, Inc. Receives Full Ownership Rights to Proprietary Polymer Patent Portfolio
SALT LAKE CITY–(BUSINESS WIRE)–Foldax® Inc. today announced that it has executed an agreement with Australia’s national science agency,…
-
Bruce Hunter named new Interim Chief Innovation and Economic Engagement Officer
By Xoel Cardenas, Sr. Communications Specialist, Office of the Vice President for Research The Partners for Innovation, Ventures, Outreach…
-
Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities
SALT LAKE CITY and TORONTO and MONTRÉAL, May 08, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading…
-
Vistim Labs Closes First Round of Funding
Vistim Labs Closes First Round of Funding
-
Culmination Bio and Cofactor Genomics Leverage Largest Biobank in the U.S. for PREDAPT Precision Medicine Clinical Trial
Respective leaders in healthcare innovation and RNA diagnostics team up to identify patients who will benefit from immunotherapy
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
